Ottimo Pharma

Sandwich, United Kingdom · Founded 2017 · Privately Held (backing)

Developer of cancer therapeutics designed to treat solid tumors. Ottimo Pharma is based in Sandwich, United Kingdom and was founded in 2017. Its last reported valuation was $242 million in Dec 2024. It has raised $150 million.

Last reported valuation
$242.4M
Oct 2026
Priced at
—
Total raised
$149.7M
Last round
—

Who backs Ottimo Pharma?

11 investors
InvestorType
Index VenturesVenture capital
OrbiMedGrowth equity
The Invus GroupPE / buyout
Samsara BioCapitalVenture capital
RTW InvestmentsHedge fund
Yucca (Jersey)Other
Avoro Capital—
Decheng Capital—
JPMorgan Life Sciences Private Capital—
Janus Henderson Investors—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Ottimo Pharma investors

11 investors are on record for Ottimo Pharma, including Index Ventures, OrbiMed, The Invus Group and Samsara BioCapital.

Free account
More of Ottimo Pharma with a free account
  • ·The complete investor list: 11 names
  • ·Watch Ottimo Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like Ottimo Pharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View